The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

ASCO GI 2021 | Personalized approaches in early esophagogastric cancer

Name: Personalized approaches in early esophagogastric cancer
Uploaded: 2021-01-18T00:00:00Z
Duration: 1 min 3 s
Description: Avani Athauda, MBBS, MRCP, The Royal Marsden NHS Foundation Trust, London, UK, explains the importance of a personalized approach to the management of patients with early esophagogastric cancer in order to reduce the rate of relapse following treatment with chemotherapy and surgery. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Avani Athauda • 18 Jan 2021

ASCO GI 2021

Esophageal Cancer Gastric Cancer Gastroesophageal Cancer Gastrointestinal Cancer

Avani Athauda, MBBS, MRCP, The Royal Marsden NHS Foundation Trust, London, UK, explains the importance of a personalized approach to the management of patients with early esophagogastric cancer in order to reduce the rate of relapse following treatment with chemotherapy and surgery. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).